# Rachel Erlich

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rachel-erlich/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,264 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 33 |
| i10-index | 46 |
| Last Known Institution | Blueprint Medicines (United States) |
| OpenAlex ID | https://openalex.org/A5004186373 |
| Works | 110 |

## Researcher papers

- [A framework for human microbiome research](https://scholariq.org/papers/a-framework-for-human-microbiome-research/)
- [Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors](https://scholariq.org/papers/activation-of-met-via-diverse-exon-14-splicing-alterations-occurs-in-multiple/)
- [Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations](https://scholariq.org/papers/characterization-of-298-patients-with-lung-cancer-harboring-met-exon-14-skipping/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Mast cells and histamine](https://scholariq.org/topics/mast-cells-and-histamine/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

## Researcher university

- [Blueprint Medicines (United States)](https://scholariq.org/institutions/blueprint-medicines-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.